Abstract
Rating scales for depression can be considered as the quantification of the symptoms included in the DSM-IV diagnosis of major depression. Among the essential psychometric properties of depression rating scales is their sensitivity to discriminate between antidepressants and placebo. Among the interview-based rating scales, the Hamilton Depression Rating Scale (HAM-D) is still the one most widely used. It is, however, not a unidimensional scale and the factors or dimensions of depression, anxiety and sleep should be analysed separately in drug trials. Among the self-rating scales, the coverage of major depression is insufficient in the most widely used scale, the Beck Depression Inventory. The scales based on DSM-IV, such as the Major Depression Inventory, should therefore be considered for use in future trials with antidepressants.
Quality of life scales are essentially self-rating scales as quality of life is a subjective dimension. Positive well-being is the core dimension of quality of life and can be considered the opposite pole to major depression. The most widely used quality of life scales are the Medical Outcome Studies (MOS) SF-36 and the Psychological General Well-Being Scale (PGWB). As a short, non-intrusive quality of life scale, the WHO-Five (which covers positive well-being items of the PGWB) should be considered in trials with antidepressants. However, the assessment of quality of life is also to be considered an attempt to see the whole of the patient when evaluating the outcome of treatment. Therefore, quality of life also covers coping skills and compliance in trials with antidepressants. The top-bottom approach of health-related quality of life in the psychopharmacological treatment of depressed patients encompasses the issues of impairments, disability, wanted and unwanted treatment effects, coping skills, compliance and subjective quality of life.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders. 3rd Ed. American Psychiatric Association, Washington, DC
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders. 4th Ed. (DSM-IV). American Psychiatric Association, Washington, DC
Beaton DE, Bombardier C, Hogg-Johnson S (1994) Choose your tool: A comparison of the psychometric properties of five generic health status instruments in workers with soft tissue injuries. Qual Life Res 3:50–56
Bech P (1989) Clinical effects of selective serotonin reuptake inhibitors. In: Dahl SG, Gram LF (eds) Clinical pharmacology in psychiatry. Springer, Berlin, pp 81–93.
Bech P (1993) Rating scales for psychopathology, health status and quality of life. Springer, Berlin
Bech P (1995) Quality-of-life measurements for patients taking which drugs? The clinical PCASEE perspective. PharmacoEconomics 7:141–151
Bech P (1996) The Bech, Hamilton and Zung Scales for mood disorders: screening and listening. Springer, Berlin
Bech P (1998) Quality of life in the psychiatric patient.Mosby-Wolfe, London
Bech P (1999) Pharmacological treatment of depressive disorders: a review. In: Maj M, Sartorius N (eds) Depressive disorders: WPA Series Evidence and Experience in Psychiatry. John Wiley & Sons, Chichester, pp 89–127
Bech P (2002a) The Bech-Rafaelsen Melancholia Scale (MES) in clinical trials of therapies in depressive disorders: a 20-year review of its use as outcome measure. Acta Psychiatr Scand 2002;106:252–264
Bech P (2002b) The Bech-Rafaelsen Mania Scale in clinical trials of therapies for bipolar disorder: 20-year review of its use as an outcome measure. CNS Drugs; 16:47–63
Bech P, Rafaelsen OJ (1980) The use of rating scales exemplified by a comparison of the Hamilton and the Bech-Rafaelsen Melancholia Scale. Acta Psychiatr Scand 62(Suppl 285):128–132
Bech P, Wermuth L (1998) Applicability and validity of the Major Depression Inventory in patients with Parkinson's disease. Nord Psychiatr J 52:305–309
Bech P, Bolwig TG, Kramp P, Rafaelsen O J (1979) The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale: evaluation of homogeneity and inter-observer reliability. Acta Psychiatr Scand 59:420–430.
Bech P, Allerup P, Gram LF, Reisby N, Rosenberg R, Jacobsen O, Nagy A (1981) The Hamilton Depression Scale: evaluation of objectivity using logistic models. Acta Psychiatr Scand 63:290–299
Bech P, Kastrup M, Rafaelsen OJ (1986) Mini-compendium of rating scales for states of anxiety, depression, mania, schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand 73(suppl 326):1–37
Bech P, Stage KB, Nair NPV, Larsen JK, Kragh-Sørensen P, GjerrisA, DUAG (1997) The major depression rating Scale (MDS): inter-rater reliability and validity across different settings in randomized moclobemide trials. J Affect Dis 42:39–48
Bech P, Rasmussen NA, Olsen LR, Noerholm V, Abildgaard W (2001) The sensitivity and specificity of the Major Depression Inventory using the Present State Examination as the index of diagnostic validity. J Affect Dis 66:159–164
Bech P, Olsen LR, Kjoller M, Rasmussen NK (2003) Measuring well-being rather than absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five well-being scale. Int J Meth Psychiatr Res (in press)
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
Beck AT, Steer RA, Ball R, Ranieri W (1996) Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients. J Pers Assess 67:588–597
Bjorner JB, Damsgaard MT, Watt T, Groenvold M (1998) Tests of data quality, scaling assumptions and reliability of the Danish SF-36. J Clin Epidemiol 51:1001–1011
Borup C, Unden M (1994) Combined fluoxetine and disulfiram treatment of alcoholism with comorbid affective disorders. A naturalistic outcome study, including quality of life measurements. Eur Psychiatry 9:83–89
Brazier JE, Harper R, Jones NMB (1992) Validating the SF-36 Health Survey questionnaire: new outcome measure for primary care. Br Med J 305:160–164
Brock DW (1988) Paternism and autonomy. Ethics 98:550–568
Clark AW (1968) The Personality and Social Network Adjustment Scale. Human Relations 21:85–96.
Cochran SD (1984) Preventing medical non-compliance in the outpatient treatment of bipolar affective disorders. J Consult Clin Psychol 5:873–878
Croog SH, Levine S, Testa M (1986) The effect of antihypertensive therapy on the quality of life. N Engl J Med 341:1657–1664
Dam J, Ryde L, Svejsø J, Lange N, Lauritsen B, Bech P (1998) Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression. Pharmacopsychiatry 73:393–400
Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L (1974) The Hopkins Symptom Checklist (HSCL). In: Pichot P (ed) Modern problems of pharmacopsychiatry. Karger, Basel, pp 79–110
Dupuy HJ (1984) The Psychological General Well-Being (PGWB) index. In: Wenger NK, Mattson ME, Furberg CD, Elison J (eds) Assessment of quality of life in clinical trials of cardiovascular therapies. Le Jacq Publishing, New York, pp 184–188
Fayers PM, Hand, DJ, Bjordal K and Groenvold M (1997) Causal indicators in quality of life research. Quality Life Res 6:393–406
Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, Munoz R (1972) Diagnostic criteria for the use in research. Arch Gen Psychiatry 26:57–63
Feinstein AR (1987) Clinimetrics. Yale University Press, New Haven
Folkman S, Chesney M, McKusick L, Ironson G, Johnson DS, Coates TJ (1991) Translating coping theory into an intervention. In Eckenrode J (ed) The social context of coping. Plenum Press, New York, pp 239–260
Frank JD (1974) Persuasion and healing. Schocken, New York
Frank JD, Hoehn-Saric R, Imber SD, Liberman BL, Stone AR (1978) Effective ingredients of successful psychotherapy. Brunner Mazel, New York
Frank E, Prien RF, Jarrett RB (1991) Conceptualization and rationale for consensus definitions of terms in major depression. Arch Gen Psychiatry 48:851–855
Freeling PR, Tylee A (1992) Depression in general practice. In: Paykel ES (ed) Handbook of affective disorders. Churchill Livingstone, Edinburgh, pp 651–663
Gandek B, Ware JE (eds) (1998) Translating functional health and well-being: international quality of life assessment (IQOLA) project studies of the SF-36 health survey. J Clin Epidemiol 51/11(Special Issue)
Goldberg D (1972) The detection of psychiatric illness by questionnaire. Oxford University Press: Oxford
Goldberg D (1978) Manual of the General Health Questionnaire. NFER, London
Goldberg DP, Hillier VF (1979) A scaled version of the General Health Questionnaire. Psychol Med 9:139–145
Anonymous (1994) Guidelines on psychotropic drugs for the EC: antidepressant medical products. Eur Neuropsychopharmacol 4:62–65
Guy W (1976) Early Clinical Drug Evaluation (ECDEU) assessment manual for psychopharmacology. National Institute of Mental Health, Rockville, MD
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiat, 23:56–62
Hamilton M (1967) Development of a rating scale for primary depressive illness. Brit J Soc Clin Psychol 6:278–296
Hamilton M, Shapiro CM (1990) Depression. In: Peck DF, Shapiro CM (eds) Measuring human problems: a practical guide. Wiley, Chichester, pp 25–65
Henkel V, Mergl R, Kohnen R, Maier W, Möller H-J, Hegerl U (2003) Identifying depression in primary care: a comparison of different methods in a prospective cohort study. BMJ 326: 200–201
Hunt SM, McKenna SP (1992) A British adaptation of the General Well-Being Index: a new tool for clinical research. Br J Med Econ 2:49–60
Hunt SM, McKenna SP (1993) Measuring quality of life in psychiatry. In: Walker SR, Rosser RM (eds.). Quality of life assessment: key issues in the 1990's. Kluwer Academic Publishers, Dordrecht, pp 343–354
Jensen HV, Plenge P, Mellerup ET, Davidsen K, Toftegaard, L, Aggernaes H, Bjørum N (1995) Lithium prophylaxis of manic depressive disorder: daily lithium dosing schedule versus every second day. Acta Psychiatr Scand 92:69–74
Kupfer DJ (1991) Long-term treatment of depression. J Clin Psychiatr 52(Suppl 5):28–34
Lauge N, Behnke K, Søgaard J, Bahr B, Bech P (1998) Responsiveness of observer rating scales by analysis of number of days until improvement in patients with major depression. Eur Psychiatry 13:143–145
Lauritzen L (1998) Screening for dementia in a normal population study of persons of 65 years or older in Karlebo Kommune. Ph.D thesis, University of Copenhagen, Copenhagen
Lazarus RS, Folkman S (1984) Stress, appraisal, and coping. Springer, New York
Lipman RS (1989) Depression scales derived from Hopkins Symptoms Checklist. In: Sartorius N, Ban TA (eds) Assessment of depression. Springer, Berlin, pp 232–248
McDowell I, Newell C (1996) Measuring health: a guide to rating scales and questionnaires. Oxford University Press, New York
McKenna SP, Hunt SM (1992) A new measure of quality of life in depression: testing the reliability and construct validity of the QLDS. Health Policy 22:321–330
Montgomery SA, Asberg M (1979) A new depression rating scale designed to be sensitive to change. Br J Psychiatry 134:382–389
Parloff MD, Kelman HC, Frank GD (1954) Comfort, effectiveness, and self-awareness as criteria for improvement in psychotherapy. Am J Psychiatry 3:343–351
Pukrop R (1997) Theoretische Explikation und empirische Validierung des Konstruktes Lebensqualitat unter besonderer Berilcksichtigung psychopathologischer Subgruppen und facettentheoretischer Methodik. Dissertation. Universität Bielefeld. Koln
Rasmussen NA, Nørholm V, Bech P (1999) Translation of the Psychological General Well-Being Schedule (PGWB). Quality of Life Newsletter 22:7
Revicki DA, Leidy NK, Howland L (1996) Evaluating the psychometric characteristics of the Psychological General Well-Being Index with a new response scale. Qual Life Res 5:419–425
Rotter JB (1966) Generalized expectancies for internal versus external control of reinforcement. Psychological Monographs 80:1–80
Rush AJ, Giles DE, Schlesser MA (1986) The Inventory of Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res 18:65–87
Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH (1996) The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 26:477–86
Rush, AJ, Carmody T, Reimitz P-E (2000) The Inventory of Depressive Symptomatology (IDS): Clinician (IDS-C) and Self-Report (IDS-SR) ratings of depressive symptoms. International J Methods in Psychiatric Research 9:45–59
Schnoll RA, Harlow LL, Brandt U, Stolbach LL (1998) Using two factor structures of the Mental Adjustment to Cancer (MAC) scale for assessing adaptation to breast cancer. Psycho-Oncology 7:424–435
Smolka M, Stieglitz RD (1999) On the validity of the Bech-Raphaelsen Melancholic Scale. J Affect Disord 54:119–128
Speer DC (1998) Mental health outcome evaluation. Academic Press, San Diego
Stewart AL, Ware JE, Sherbourne CD, Wells KB (1992) Psychological distress/well-being and cognitive functioning measures. In: Stewart AL, Ware JE (eds.) Measuring functioning and well-being. Duke University Press, Durham, pp 102–142.
Thunedborg K, Black C, Bech P (1995) Beyond the Hamilton Depression Scale scores in manic-melancholic patients in long term relapse-prevention: a quality of life approach. Psychother Psychosom 64:131–140
Tuynman-Qua HG, De Jonghe F, McKenna S, Hunt S (1992) Quality of life in depression scale. Ibero, Houten The Netherlands
Vieweg BW, Hedlund JC (1983) The General Health Questionnaire (GHQ): a comprehensive review. J Operat Psychiat 14:74–85
Ware JE, Gandek B (1994) The SF-36 health survey: development and use in mental health research and the IQOLA Project. Int J Mental Health 23:49–73
Ware JE, Johnston SA, Davies-Avery A (1979) Conceptuation and measurement of health for adults in the Health Insurance Study. Publication no. R-1987/3. Rand Corporation, Santa Monica, California
Wells KB, Burman MA, Rogers W (1992) The course of depression in adult outpatients: results from the Medical Outcomes Study. Arch Gen Psychiatry 49:788–794
Winokur G (1995) Manic-depressive disease (bipolar): is it autonomous? Psychopathology 28(suppl 1):51–58
World Health Organization (1980) International classification of impairments, disabilities and handicaps (ICDIDH/WHO). World Health Organization, Geneva
World Health Organization (1993) International Classification of Diseases, tenth revision (ICD-10). Geneva: World Health Organization
World Health Organization (1998) Use of well-being measures in primary health care: the DEPCARE project. World Health Organization, Regional Office for Europe, Copenhagen
Zitman FG, Mennen MF, Griez E, Hooijer Cl (1990) The different versions of the Hamilton Depression Rating Scale. Psychopharmacol Ser 9:28–34
Zung WWK (1965) A self-rating depression scale. Arch Gen Psychiatry 12:63–70
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bech, P. (2004). Quality of Life and Rating Scales of Depression. In: Preskorn, S.H., Feighner, J.P., Stanga, C.Y., Ross, R. (eds) Antidepressants: Past, Present and Future. Handbook of Experimental Pharmacology, vol 157. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18500-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-18500-7_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62135-2
Online ISBN: 978-3-642-18500-7
eBook Packages: Springer Book Archive